<?xml version="1.0" encoding="UTF-8"?>
<document>
<type>mainstream</type>
<forum>http://feeds.benzinga.com/benzinga/press-releases</forum>
<forum_title>Press Releases</forum_title>
<discussion_title>Ocular Inflammation Market - Global API Manufacturers, Marketed and Phase III Drugs Landscape 2016 - Research and Markets</discussion_title>
<language>english</language>
<gmt_offset></gmt_offset>
<topic_url>http://www.benzinga.com/pressreleases/16/04/b7879503/ocular-inflammation-market-global-api-manufacturers-marketed-and-phase-</topic_url>
<topic_text>
April 25, 2016 2:21pm Comments Share: DUBLIN--(BUSINESS WIRE)-- 
Research and Markets has announced the addition of the &quot;Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016&quot; report to their offering. 
Ocular Inflammation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. 
A key objective of the Ocular Inflammation Report is to understand the market and pipeline status of the drugs around Ocular Inflammation to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018. 
The Ocular Inflammation Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across Ocular Inflammation. 
While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India. 
Key Topics Covered:
</topic_text>
<spam_score>0.00</spam_score>
<post_num>1</post_num>
<post_id>post-1</post_id>
<post_url>http://www.benzinga.com/pressreleases/16/04/b7879503/ocular-inflammation-market-global-api-manufacturers-marketed-and-phase-</post_url>
<post_date>20160425</post_date>
<post_time>1821</post_time>
<username>Business Wire</username>
<post>
April 25, 2016 2:21pm Comments Share: DUBLIN--(BUSINESS WIRE)-- 
Research and Markets has announced the addition of the &quot;Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016&quot; report to their offering. 
Ocular Inflammation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. 
A key objective of the Ocular Inflammation Report is to understand the market and pipeline status of the drugs around Ocular Inflammation to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018. 
The Ocular Inflammation Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across Ocular Inflammation. 
While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India. 
Key Topics Covered:
</post>
<signature>

</signature>
<external_links>

</external_links>
<country>US</country>
<main_image></main_image>
</document>
